Low-Dose GLP-1 Therapy Outperforms High-Dose Escalation for Weight Loss
The speaker, a DC (Doctor of Chiropractic), claims that lower doses of GLP-1 medications produce better outcomes than the standard escalating-dose protocol. He argues that patients achieve superior results by finding the lowest effective dose that reduces food cravings ('food chatter') without fully eliminating appetite. No specific dosage numbers (mcg or mg) are provided, and no clinical studies are cited — the claim is based on self-reported clinical observation.